Axon beats Q1 revenue estimates, raises FY outlook

Axovant Sciences Ltd

Axovant Sciences Ltd

AXON

0.00


Overview

  • US public safety tech firm's Q1 revenue rose 34% yr/yr, beating analyst expectations

  • Adjusted EPS and net income increased yr/yr, driven by higher operating income

  • Company raised 2026 revenue growth outlook to 30%-32% from 27%-30%


Outlook

  • Axon raises full-year 2026 revenue growth outlook to 30%-32%, up from 27%-30%

  • Company maintains full-year 2026 Adjusted EBITDA margin guidance at 25.5%

  • Axon expects 2026 capital expenditures of $160 mln to $190 mln


Result Drivers

  • SOFTWARE & SERVICES GROWTH - Co said 35% yr/yr revenue growth in Software & Services was driven by new users and increased adoption of premium software offerings

  • AI AND COUNTER-DRONE DEMAND - AI products revenue rose over 700% and counter-drone product revenue increased over 300% yr/yr, reflecting strong customer adoption

  • GROSS MARGIN PRESSURE - Gross margin declined yr/yr due to global tariffs and increased professional services costs related to product deployments, especially Dedrone


Company press release: ID:nPn7R50RZa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

Beat

$807 mln

$778.45 mln (15 Analysts)

Q1 EPS

$2.05

Q1 Net Income

$169 mln

Q1 Adjusted EBITDA

$202 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 20 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the aerospace & defense peer group is "buy"

  • Wall Street's median 12-month price target for Axon Enterprise Inc is $686.00, about 80.2% above its May 5 closing price of $380.60

  • The stock recently traded at 44 times the next 12-month earnings vs. a P/E of 64 three months ago


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.